AstraZeneca Buys $4 Billion Stake In Acerta Pharma

AstraZeneca Buys $4 Billion Stake In Acerta Pharma - a biotech company based in Netherlands with a pipeline full of drugs in both the blood cancer space, and autoimmune diseases space.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.